Aclaris Therapeutis (ACRS) PT Lowered to $34 at JMP Securities

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Aclaris Therapeutis (ACRS) PT Lowered to $34 at JMP Securities

Aclaris Therapeutics (ACRS) Prices 8.6645M Share Common Offering at $10.75/Sh

October 18, 2018 5:45 AM EDT

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) today announced the pricing of its underwritten public offering of 8,645,000 shares of its common stock at a price to the public of $10.75 per share. In addition, Aclaris has granted to the underwriters a 30-day option to purchase up to... More

Aclaris Therapeutics (ACRS) Announces Proposed Common Share Offering

October 17, 2018 4:01 PM EDT

Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to address significant unmet patient needs in aesthetic and medical dermatology and immunology, today announced that it intends to offer and sell, subject to market... More